HMGB1 signaling blocking protects against carbapenem-resistant klebsiella pneumoniae in a murine model of infection

References

• Akova M, Daikos GL, Tzouvelekis L, et al. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012;18(5):439–448.
   PubMed Web of Science ®Google Scholar
• Shankar PR. Book review: Tackling drug-resistant infections globally. Arch Pharma Pract. 2016;7(3):110–111.
   Web of Science ®Google Scholar
• Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus Surgical Site Infection. Clin Infect Dis. 2003;36(5):592–598.
   PubMed Web of Science ®Google Scholar
• Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 2005;26(2):175–183.
   PubMed Web of Science ®Google Scholar
• Happel KI, Zheng M, Young E, et al. Cutting Edge: Roles of Toll-Like Receptor 4 and IL-23 in IL-17 Expression in Response to Klebsiella pneumoniae Infection. J Immunol. 2003;170(9):4432–4436.
   PubMed Web of Science ®Google Scholar
• Mehling JS, Lavender H, Clegg S. A Dam methylation mutant of Klebsiella pneumoniae is partially attenuated. Fems Microbiol Lett. 2007;268(2):187–193.
   PubMed Web of Science ®Google Scholar
• Cryz S Jr, Fürer E, Germanier R. Immunization against fatal experimental Klebsiella pneumoniae pneumonia. Infect Immun. 1986;54(2):403.
   PubMed Web of Science ®Google Scholar
• Petrosillo N, Giannella M, Lewis R, et al. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther. 2013;11(2):159–177.
   PubMed Web of Science ®Google Scholar
• Ma L, Zeng J, Mo B, et al. High mobility group box 1: a novel mediator of Th2-type response-induced airway inflammation of acute allergic asthma. J Thorac Dis. 2015;7(10):1732–1741.
   PubMed Web of Science ®Google Scholar
• Ullah MA, Loh Z, Gan WJ, et al. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation. J Allergy Clin Immunol. 2014;134(2):440–450.
   PubMed Web of Science ®Google Scholar
• Yanai H, Matsuda A, An J, et al. Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. PNAS 2013;110(51):20699–20704.
   PubMed Web of Science ®Google Scholar
• Zhang F, Huang G, Hu B, et al. Anti-HMGB1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell-mediated Th17 polarization. Mediators Inflamm. 2014;2014:257930.
   PubMedGoogle Scholar
• Hilliard JJ, Melton JL, Hall LR, et al. Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae Murine Pneumonia Model. Antimicrob Agents Chemother. 2011;55(2):836–844.
   PubMed Web of Science ®Google Scholar
• Huang W, Yao Y, Long Q, et al. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. Plos One. 2014;9(6):e100727.
   PubMed Web of Science ®Google Scholar
• Hori T, Nakano M, Kimura Y, et al. Pharmacokinetics and tissue penetration of a new carbapenem, doripenem, intravenously administered to laboratory animals. In Vivo. 2006;20(1):91–96.
   PubMed Web of Science ®Google Scholar
• Cortés G, Álvarez D, Saus C, et al. Role of lung epithelial cells in defense against Klebsiella pneumoniae Pneumonia. Infect Immun. 2002;70(3):1075–1080.
   PubMed Web of Science ®Google Scholar
• Peto L, Nadjm B, Horby P, et al. The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review. Trans R Soc Trop Med Hyg. 2014;108(6):326–337.
   Web of Science ®Google Scholar
• Lau HY, Huffnagle GB, Moore TA. Host and microbiota factors that control Klebsiella pneumoniae mucosal colonization in mice. Microbes Infect. 2008;10(12–13):1283–1290.
   PubMed Web of Science ®Google Scholar
• Niemelä SI, Väätänen P, Mentu J, et al. Microbial incidence in upper respiratory tracts of workers in the paper industry. Appl Environ Microbiol. 1985;50(1):163–168.
   PubMed Web of Science ®Google Scholar
• Lau HY, Clegg S, Moore TA. Identification of Klebsiella pneumoniae genes uniquely expressed in a strain virulent using a murine model of bacterial Pneumonia. Microb Pathogen. 2007;42(4):148–155.
   PubMed Web of Science ®Google Scholar
• Laichalk LL, Kunkel SL, Strieter RM, et al. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect Immun. 1996;64(12):5211–5218.
   PubMed Web of Science ®Google Scholar
• Pichardo C, Conejo MDC, Bernabéu-Wittel M, et al. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae, producing FOX-5 β-lactamase. Clin Microbiol Infect. 2005;11(1):31–38.
   PubMed Web of Science ®Google Scholar
• Chiang S-R, Chuang Y-C, Tang H-J, et al. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii. Crit Care Med. 2009;37(9):2590–2595.
   PubMed Web of Science ®Google Scholar
• Horii T, Kobayashi M, Sato K, et al. An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli. J Antimicrob Chemother. 1998;41(4):435–442.
   PubMed Web of Science ®Google Scholar
• Band VI, Satola SW, Burd EM, et al. Carbapenem-Resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a Murine Model of Infection. mBio 2018;9(2):e02448.
   PubMed Web of Science ®Google Scholar
• Alekshun MN, Levy SB. Molecular mechanisms of antibacterial multidrug resistance. Cell 2007;128(6):1037–1050.
   Web of Science ®Google Scholar
• Clancy CJ, Chen L, Shields RK, et al. Epidemiology and molecular characterization of bacteremia due to Carbapenem-Resistant Klebsiella pneumoniae in Transplant Recipients. Am J Transplant. 2013;13(10):2619–2633.
   PubMed Web of Science ®Google Scholar
• Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54–60.
   PubMed Web of Science ®Google Scholar
• Lisa SO, Abraham B. Limiting and controlling carbapenem-resistantKlebsiella pneumoniae. Infect Drug Res. 2014;7:9–14.
   Web of Science ®Google Scholar
• Venereau E, Casalgrandi M, Schiraldi M, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med. 2012;209(9):1519–1528.
   Web of Science ®Google Scholar
• Lu B, Wang H, Andersson U, et al. Regulation of HMGB1 release by inflammasomes. Protein Cell. 2013;4(3):163–167.
   PubMed Web of Science ®Google Scholar
• Bianchi ME, Manfredi AA. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev. 2007;220:35–46.
   PubMed Web of Science ®Google Scholar
• Allonso D, Belgrano FS, Calzada N, Guzmán MG, Vázquez S, Mohana-Borges R. Elevated serum levels of high mobility group box 1 (HMGB1) protein in dengue-infected patients are associated with disease symptoms and secondary infection. J Clin Virol. 2012;55:214–219.
   PubMed Web of Science ®Google Scholar
• Yamada S, Maruyama I. HMGB1, a novel inflammatory cytokine. Clin Chim Acta. 2007;375(1–2):36–42.
   PubMed Web of Science ®Google Scholar
• Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279(9):7370–7377.
   PubMed Web of Science ®Google Scholar
• Nogueira-Machado JA, de Oliveira Volpe CM. HMGB-1 as a target for inflammation controlling. Recent Pat Endocr Metab Immune Drug Discov. 2012;6:201–209.
   PubMedGoogle Scholar
• Nosaka N, Yashiro M, Yamada M, et al. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice. Crit Care. 2015;19(1):249.
   PubMedGoogle Scholar
• Kosai K, Seki M, Yanagihara K, et al. Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand J Infect Dis. 2008;40(4):338–342.
   PubMed Web of Science ®Google Scholar
• Fink MP. HMGB1 as a drug target in staphylococcal pneumonia. Crit Care. 2014;18(2):131.
   PubMed Web of Science ®Google Scholar